ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
wessomart
|
289 |
133K |
2 |
15/10/19 |
15/10/19 |
ASX - By Stock
|
289
|
133K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
wessomart
|
289 |
133K |
5 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
289
|
133K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
wessomart
|
152 |
54K |
2 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
152
|
54K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
wessomart
|
170 |
65K |
1 |
21/04/19 |
21/04/19 |
ASX - By Stock
|
170
|
65K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Preliminary Final Report for period to 31 December 2018
|
|
wessomart
|
62 |
27K |
1 |
03/03/19 |
03/03/19 |
ASX - By Stock
|
62
|
27K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Preliminary Final Report for period to 31 December 2018
|
|
wessomart
|
62 |
27K |
13 |
02/03/19 |
02/03/19 |
ASX - By Stock
|
62
|
27K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Promising Interim Results from TAVR Animal Study
|
|
wessomart
|
63 |
27K |
3 |
19/02/19 |
19/02/19 |
ASX - By Stock
|
63
|
27K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
wessomart
|
107 |
39K |
5 |
21/01/19 |
21/01/19 |
ASX - By Stock
|
107
|
39K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
General commentary in reference to resume of trading.
|
|
wessomart
|
57 |
23K |
9 |
29/11/18 |
29/11/18 |
ASX - By Stock
|
57
|
23K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus launches rights issue
|
|
wessomart
|
250 |
85K |
6 |
28/11/18 |
28/11/18 |
ASX - By Stock
|
250
|
85K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Interim CFO Appointment
|
|
wessomart
|
9 |
5.6K |
0 |
27/11/18 |
27/11/18 |
ASX - By Stock
|
9
|
5.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Director Appointment/Resignation
|
|
wessomart
|
177 |
67K |
5 |
08/10/18 |
08/10/18 |
ASX - By Stock
|
177
|
67K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Under the Radar
|
|
wessomart
|
538 |
235K |
11 |
03/10/18 |
03/10/18 |
ASX - By Stock
|
538
|
235K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
So what exactly did WP say, not say, and imply in the AGM meeting.
|
|
wessomart
|
87 |
37K |
1 |
05/08/18 |
05/08/18 |
ASX - By Stock
|
87
|
37K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
wessomart
|
268 |
85K |
7 |
01/08/18 |
01/08/18 |
ASX - By Stock
|
268
|
85K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Admedus then and NOW
|
|
wessomart
|
23 |
10K |
3 |
03/06/18 |
03/06/18 |
ASX - By Stock
|
23
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus enters distribution agreement for Spain
|
|
wessomart
|
75 |
21K |
0 |
18/05/18 |
18/05/18 |
ASX - By Stock
|
75
|
21K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
The Cap Raising - feedback from management
|
|
wessomart
|
128 |
39K |
7 |
08/05/18 |
08/05/18 |
ASX - By Stock
|
128
|
39K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
It’s all about Adapt
|
|
wessomart
|
183 |
78K |
0 |
29/01/18 |
29/01/18 |
ASX - By Stock
|
183
|
78K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Top 20
|
|
wessomart
|
123 |
41K |
0 |
07/12/17 |
07/12/17 |
ASX - By Stock
|
123
|
41K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Top 20
|
|
wessomart
|
123 |
41K |
5 |
07/12/17 |
07/12/17 |
ASX - By Stock
|
123
|
41K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Top 20
|
|
wessomart
|
123 |
41K |
0 |
07/12/17 |
07/12/17 |
ASX - By Stock
|
123
|
41K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Top 20
|
|
wessomart
|
123 |
41K |
1 |
07/12/17 |
07/12/17 |
ASX - By Stock
|
123
|
41K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Regulatory approval to launch CardioCel in India
|
|
wessomart
|
69 |
23K |
0 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
69
|
23K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Upcoming Immunotherapies Deal (???)
|
|
wessomart
|
54 |
19K |
1 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
54
|
19K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Upcoming Immunotherapies Deal (???)
|
|
wessomart
|
54 |
19K |
2 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
54
|
19K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Upcoming Immunotherapies Deal (???)
|
|
wessomart
|
54 |
19K |
8 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
54
|
19K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Upcoming Immunotherapies Deal (???)
|
|
wessomart
|
54 |
19K |
0 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
54
|
19K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Upcoming Immunotherapies Deal (???)
|
|
wessomart
|
54 |
19K |
1 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
54
|
19K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Upcoming Immunotherapies Deal (???)
|
|
wessomart
|
54 |
19K |
0 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
54
|
19K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Questions for AGM
|
|
wessomart
|
104 |
31K |
0 |
20/11/17 |
20/11/17 |
ASX - By Stock
|
104
|
31K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Live Stream Webinar Registration Open
|
|
wessomart
|
197 |
68K |
6 |
20/11/17 |
20/11/17 |
ASX - By Stock
|
197
|
68K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Live Stream Webinar Registration Open
|
|
wessomart
|
197 |
68K |
0 |
17/11/17 |
17/11/17 |
ASX - By Stock
|
197
|
68K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Exclusive Supply Agreement with 4C Medical
|
|
wessomart
|
97 |
29K |
0 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
97
|
29K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Exclusive Supply Agreement with 4C Medical
|
|
wessomart
|
97 |
29K |
2 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
97
|
29K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Awesome Week Ahead #awesomeweekahead
|
|
wessomart
|
38 |
16K |
6 |
13/11/17 |
13/11/17 |
ASX - By Stock
|
38
|
16K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Immunotherapy Partner Patrick Soon Shiong
|
|
wessomart
|
24 |
9.0K |
1 |
06/11/17 |
06/11/17 |
ASX - By Stock
|
24
|
9.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Admedus Trend line
|
|
wessomart
|
65 |
28K |
1 |
06/11/17 |
06/11/17 |
ASX - By Stock
|
65
|
28K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AHZ RESPONDS TO MEDIA SPECULATION
|
|
wessomart
|
11 |
4.3K |
0 |
02/11/17 |
02/11/17 |
ASX - By Stock
|
11
|
4.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AHZ RESPONDS TO MEDIA SPECULATION
|
|
wessomart
|
11 |
4.3K |
0 |
02/11/17 |
02/11/17 |
ASX - By Stock
|
11
|
4.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
response from WP - re 4C
|
|
wessomart
|
83 |
23K |
2 |
01/11/17 |
01/11/17 |
ASX - By Stock
|
83
|
23K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
wessomart
|
186 |
54K |
3 |
01/11/17 |
01/11/17 |
ASX - By Stock
|
186
|
54K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
wessomart
|
186 |
54K |
5 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
186
|
54K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
TootToot - Trainwreck
|
|
wessomart
|
33 |
11K |
3 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
33
|
11K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
TootToot - Trainwreck
|
|
wessomart
|
33 |
11K |
3 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
33
|
11K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
TootToot - Trainwreck
|
|
wessomart
|
33 |
11K |
2 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
33
|
11K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
TootToot - Trainwreck
|
|
wessomart
|
33 |
11K |
2 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
33
|
11K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
wessomart
|
186 |
54K |
7 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
186
|
54K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
wessomart
|
186 |
54K |
5 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
186
|
54K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
TootToot - Trainwreck
|
|
wessomart
|
33 |
11K |
9 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
33
|
11K
|
9
|
|